Search the Newsreel

Form 8K Goldman Sachs Group For: 11 August By Investing.com

(LMB) Price Dynamics and Execution-Aware Positioning

This article provides an AI-generated analysis of Limbach Holdings Inc. (NYSE: LMB), highlighting weak sentiment across all horizons, supporting a short bias with elevated downside risk. It details three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. …

GCPB Holdings & Weightings | Goldman Sachs Core Plus Bond ETF

This article provides a detailed breakdown of the Goldman Sachs Core Plus Bond ETF (GCPB) holdings and weightings. It includes a list of its top 10 holdings, asset allocations (bonds, cash, preferred, stocks), and sector allocations (securitized, government, corporate). The article also notes that …

Goldman Sachs Income ETF Historical Data

This article provides historical data for the Goldman Sachs Income ETF (GINC), including closing price, open, high, low, volume, and daily percentage change. It also offers a general overview of GINC, its current trading metrics, and an FAQ section regarding its daily trading range …

Achieve Life Sciences (ACHV) swings to larger $84.9M loss on warrant costs

Huachen AI Parking Management Technology Holding Co. Ltd. Class A (HCAI) Live Share Price, Invest From India

This article provides a detailed financial overview of Huachen AI Parking Management Technology Holding Co. Ltd. Class A (HCAI), including its live share price, historical returns, key fundamental indicators, and peer comparison. It also features quarterly and annual profit/loss statements, cash flow, and global …

ACHIEVE LIFE SCIENCES, INC. 6M 2026: Net loss $(84.9)M, EPS $(1.15) — 10-Q Summary

ACHIEVE LIFE SCIENCES, INC. reported a consolidated net loss of $(84.9)M for the six months ended June 30, 2026, an increase from a $(25.5)M loss in the prior year. The diluted loss per share was $(1.15) for the same period, compared to $(0.74) in …

Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financing

Achieve Life Sciences reported a larger Q2 2026 net loss of $74.8 million but secured up to $354 million in financing, including $180 million upfront. The company received an FDA Complete Response Letter for its cytisinicline NDA due to manufacturing and labeling issues, not …

Las acciones de Goldman Sachs (GS) parecen tener un precio justo en términos de valor, pero baratas en términos de beneficios

Goldman Sachs (GS) Stock Looks Fairly Priced On Value But Cheap On Earnings

Bronstein, Gewirtz & Grossman, LLC Is Investigating Limbach Holdings, Inc. (LMB) And Encourages Stockholders to Connect

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential claims against Limbach Holdings, Inc. (LMB) following the company's lowered full-year 2026 Adjusted EBITDA guidance and reported second-quarter results that fell below analyst consensus. The firm is encouraging investors who purchased Limbach securities …

Blackstone hired a Goldman Sachs MD from the team schmoozing private credit firms

Blackstone has hired Anna Montvai, a managing director from Goldman Sachs's capital solutions group, to join its credit and insurance team in London. Montvai, who specializes in asset-backed finance and securitization, spent 16 years at Goldman Sachs. This move highlights the ongoing talent flow …

Seeing Machines reports profitable second half as revenue surges

Goldman Sachs (GS) Stock May Be A Bargain On Earnings But Fairly Valued Overall

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Goldman Sachs Group stock has put in a very strong three year run, yet current valuation checks suggest the shares now sit closer …

Goldman Sachs Group (FACT) discloses 4.1% holding in FACT II Acquisition

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 4.1% beneficial ownership in FACT II Acquisition Corp, totaling 756,137 Class A ordinary shares. This information comes from an amended Schedule 13G filing, which indicates shared voting and dispositive …

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History

This article provides comprehensive financial information for Accendra Health, Inc. (ACH), including its stock price, historical data, and recent news. It covers the company's profile as a healthcare solutions provider, its financial performance, earnings trends, and analyst insights. The data indicates significant negative returns …

The Bull Case For Goldman Sachs Group (GS) Could Change Following NVIDIA’s $500B AI Compute Financing Push

In August 2026, NVIDIA announced it had signed memorandums of understanding with Goldman Sachs and five other major financial institutions to create independent compute financing platforms that could mobilize over US$500.00 billion of third-party capital for AI infrastructure across its ecosystem, subject to final …

International Business Machines (IBM), What Is Driving Fresh Attention Today?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. International Business Machines (IBM) has just completed a CAD 997.11 million fixed income offering of 4.750% notes due August 15, 2034. This provides …

Achieve Life Sciences (NASDAQ:ACHV) Posts Earnings Results, Misses Expectations By $0.12 EPS

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly earnings of $(0.28) per share, falling short of analysts' consensus estimates by $0.12. Despite missing earnings expectations, ACHV shares saw a slight increase of 0.7% to $6.71, and institutional investors collectively own a significant portion of the company. …

Goldman's M&A Leadership Bodes Well: Should You Buy GS Stock Now?

The Goldman Sachs Group, Inc. GS continues to strengthen its position in the global dealmaking landscape, with its latest merger and acquisition (M&A) league-table performance underscoring the depth of its investment-banking (IB) franchise. Goldman ranked the top financial adviser on mergers and acquisitions in …

Beachbody (NASDAQ:BODI) Issues Earnings Results, Beats Estimates By $0.26 EPS

The Beachbody Company, Inc. (BODI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to a loss of $0.57 per share a year ago. These figures are adjusted for non-recurring …

Achieve Life Sciences (ACHV) Advances Cytisinicline Commercialization Amid Mixed Valuation Signals

IBM, Together AI Ink $240M Agreement to Scale AI Deployments

IBM and Together AI have announced a significant collaboration worth $240 million, aimed at scaling AI deployments. This partnership focuses on enhancing enterprise AI capabilities and accelerating the adoption of AI solutions across various industries. The agreement underscores a commitment to integrating advanced AI …

Turtle Beach Corp (TBCH): Hoak group cuts stake below 5% in exit filing

The Hoak group has filed an amended Schedule 13D for Turtle Beach Corp (TBCH), indicating they have reduced their ownership below the 5% threshold, thus constituting an exit filing. Hoak Public Equities, L.P. now directly owns 4.14% of the outstanding shares, with other Hoak-affiliated …

Achieve Life Sciences GAAP EPS of -$0.80 misses by $0.64

* Achieve Life Sciences press release [https://seekingalpha.com/pr/20614674-achieve-life-sciences-reports-second-quarter-2026-financial-results-and-provides-business] (ACHV [https://seekingalpha.com/symbol/ACHV]): Q2 GAAP EPS of -$0.80 misses by $0.64. * As of June 30, 2026, the Company’s cash, cash equivalents, and marketable securities were $187.3 million. MORE ON ACHIEVE LIFE SCIENCES * Achieve Life Sciences: Despite …

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

Achieve Life Sciences announced its second-quarter 2026 financial results, highlighted by closing a private placement of up to $354 million. The company received a Complete Response Letter from the FDA for cytisinicline's NDA due to cGMP issues and incomplete labeling, but no deficiencies in …

Goldman Sachs Preferreds Strategy Update: Hold Rated (NYSE:GS.PR.A)

This article analyzes Goldman Sachs' three preferred stocks, highlighting their similar floating rate formula with a floor rate. While Goldman Sachs demonstrates strong dividend and par value coverage, making default on preferred dividends unlikely, the author rates all three as "Holds" due to what …

IBM Signs $240M AI Cloud Agreement With Together AI | IBM Stock News

IBM has signed a multi-year, $240 million agreement with Together AI to deploy a large cluster of NVIDIA HGX B300 systems on IBM Cloud by Q1 2027. This collaboration aims to provide Together AI with dedicated, high-performance infrastructure for open-source AI model inference, which …

Goldman Sachs warns AI investment may be crowding out other business spending

Investing.com -- Goldman Sachs said the surge in artificial intelligence spending may be crowding out other business activity, though it found only limited evidence of that effect so far. In a note to clients, analyst Jessica Rindels estimated AI investment in the U.S. will …

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

Baird has downgraded Accendra Health (ACH) from an "Outperform" rating to "Neutral" and significantly lowered its price target from $6 to $1.50. This change in rating and price target follows other recent analyst adjustments, indicating a more cautious outlook for the company. Accendra Health …

Chongqing Machinery & Electric forecasts 30% rise in first-half 2026 profit

Handelsbanken Fonder AB Has $179.47 Million Position in International Business Machines Corporation $IBM

Handelsbanken Fonder AB significantly increased its stake in International Business Machines Corporation (IBM) by 86.7% in the second quarter, now holding 638,216 shares valued at $179.47 million. Other institutional investors also adjusted their positions in IBM, which currently has a market capitalization of $222.12 …

Goldman Sachs Adjusts Price Target on Phillips 66 to $245 From $235, Maintains Neutral Rating

Goldman Sachs has increased its price target for Phillips 66 (NYSE: PSX) to $245 from $235, while reiterating a Neutral rating on the stock. This adjustment reflects a positive outlook on the company's valuation by the investment bank. The article also provides a brief …

KMG Fiduciary Partners LLC Has $4.28 Million Stock Position in International Business Machines Corporation $IBM

KMG Fiduciary Partners LLC reduced its stake in International Business Machines Corporation (IBM) by 52.7% in the second quarter, now holding 15,228 shares valued at approximately $4.28 million. Despite institutional investors owning nearly 59% of the stock, IBM's recent quarterly earnings met expectations at …

International Business Machines Corp. (IBM) News, Articles, Events & Latest Updates

IBM has signed a significant multi-year deal worth $240 million with Together AI to deploy NVIDIA HGX B300 systems for large-scale AI inference on IBM Cloud, with availability expected in Q1 2027. This agreement has caused IBM shares to rise and positions the company …

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

This press release from Accendra Health reports their financial results for the second quarter of 2026. Further details on their performance would be contained within the full report.